Cedric Francois - Chief Executive Officer, Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Issuer Symbol: APLS on Nasdaq
All Insider Reports: All Insider Reports

Cedric Francois - trading volume in the past year for Apellis Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-429,650	100%	$24.54	-$10,544,358
Net	-429,650	-100%		-$10,544,358

Holdings reported by Cedric Francois for Apellis Pharmaceuticals, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	472,065	$11,858,320	$25.12	03 Feb 2026	Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)
Common Stock	307,946	$7,735,634	$25.12	03 Feb 2026	Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Common Stock	300,000	$7,536,030	$25.12	03 Feb 2026	Indirect Owner (The Francois Grossi Trust)
Common Stock	234,411	$5,888,427	$25.12	03 Feb 2026	Indirect Owner (The Francois-DuBois Educational Trust)
Stock Option (Right to Buy)	0	$5,574,625	$19.39	03 Feb 2026	Direct	Common Stock
Common Stock	490,837	$1,845,547	$3.76	03 Feb 2026	Direct

Transactions reported by Cedric Francois for Apellis Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.